Philippe Moerman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Philippe Moerman has a total of 82 co-authors. Here are the top co-authors by number of shared publications:
- Ignace Vergote
University Hospital Leuven, Leuven Cancer Institute , Leuven, Belgium, European Union
7 shared publications - Frédéric Amant
Department of oncology, KU Leuven, Leuven, Belgium
6 shared publications - Diether Lambrechts
Laboratory for Translational Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium
2 shared publications - Frederik De Keyzer
Department of Radiology, University Hospitals Leuven, Leuven, Belgium
2 shared publications - Katrijn L M Michielsen
Department of Radiology, University Hospitals Leuven; Herestraat 49, 3000 Leuven, Belgium
2 shared publications - Luc De Catte
My FetUZ Fetal Research Center, Department of Development and Regeneration Cluster Women and Child, Biomedical Sciences, KU Leuven Leuven Belgium
2 shared publications
Latest Publications
- 1 October 2018
- Published by Elsevier in Gynecologic Oncology
- Vol. 151 (1) , 61-68
The genetic landscape of 87 ovarian germ cell tumors
- 1 October 2018
- Published by Elsevier in Gynecologic Oncology
- Vol. 151 (1) , 61-68
The genetic landscape of 87 ovarian germ cell tumors
- 1 September 2017
- Published by Elsevier in European Journal of Cancer
- Vol. 83, 88-98
Diagnostic value of whole body diffusion-weighted MRI compared to computed tomography for pre-operative assessment of patients suspected for ovarian cancer
- 1 September 2017
- Published by Elsevier in European Journal of Cancer
- Vol. 83, 88-98
Diagnostic value of whole body diffusion-weighted MRI compared to computed tomography for pre-operative assessment of patients suspected for ovarian cancer
- 1 November 2016
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 89 (1067) , 20160468
Whole-body diffusion-weighted magnetic resonance imaging in the diagnosis of recurrent ovarian cancer: a clinical feasibility study
Objective:To assess the clinical feasibility of whole-body diffusion-weighted MRI (WB-DWI/MRI) for diagnosis and prediction of complete tumour resection in patients with suspected recurrent ovarian cancer.Methods:51 females clinically suspected for ovarian cancer recurrence underwent 3-T WB-DWI/MRI in addition to contrast-enhanced CT. WB-DWI/MRI was assessed for detection of tumour recurrence, prediction of tumour extent and complete resection compared with CT. Tumour presence was confirmed by pathology obtained by surgery or biopsy, or by imaging follow-up.Results:WB-DWI/MRI showed 94% accuracy for detecting ovarian cancer recurrence, compared with 78% for CT (p = 0.008). WB-DWI/MRI showed better sensitivity [% (95% confidence interval)] than CT for detecting involvement of surgically critical tumour sites including mesenteric root infiltration [92 (62–100) vs 31 (10–61)], small bowel [93 (64–100) vs 21 (6–51)], colon carcinomatosis [91 (57–100) vs 27 (7–61)] and unresectable distant metastases [90 (54–9...
- 1 November 2016
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 89 (1067) , 20160468
Whole-body diffusion-weighted magnetic resonance imaging in the diagnosis of recurrent ovarian cancer: a clinical feasibility study
Objective:To assess the clinical feasibility of whole-body diffusion-weighted MRI (WB-DWI/MRI) for diagnosis and prediction of complete tumour resection in patients with suspected recurrent ovarian cancer.Methods:51 females clinically suspected for ovarian cancer recurrence underwent 3-T WB-DWI/MRI in addition to contrast-enhanced CT. WB-DWI/MRI was assessed for detection of tumour recurrence, prediction of tumour extent and complete resection compared with CT. Tumour presence was confirmed by pathology obtained by surgery or biopsy, or by imaging follow-up.Results:WB-DWI/MRI showed 94% accuracy for detecting ovarian cancer recurrence, compared with 78% for CT (p = 0.008). WB-DWI/MRI showed better sensitivity [% (95% confidence interval)] than CT for detecting involvement of surgically critical tumour sites including mesenteric root infiltration [92 (62–100) vs 31 (10–61)], small bowel [93 (64–100) vs 21 (6–51)], colon carcinomatosis [91 (57–100) vs 27 (7–61)] and unresectable distant metastases [90 (54–9...
- 28 July 2016
- Published by SAGE Publications in International Journal of Surgical Pathology
- Vol. 24 (7) , 635-639
Mesonephric (Wolffian) Pseudoendometrioid Carcinoma of the Broad Ligament, Arising From a Papillary Cystadenoma
This article describes the case of a 70-year-old woman with an adnexal cystadenocarcinoma located in the right broad ligament and displaying a striking resemblance to a well-differentiated endometrioid adenocarcinoma. The uniqueness of this pseudoendometrioid carcinoma lies in the fact that its mesonephric nature is revealed by the origin from a papillary cystadenoma of the broad ligament, where remnants of the mesonephric duct are seated, and the immunohistochemical profile, particularly a uniform negativity for estrogen and progesterone receptors, apical-luminal positivity for CD10, and strong nuclear positivity for GATA3.
- 28 July 2016
- Published by SAGE Publications in International Journal of Surgical Pathology
- Vol. 24 (7) , 635-639
Mesonephric (Wolffian) Pseudoendometrioid Carcinoma of the Broad Ligament, Arising From a Papillary Cystadenoma
This article describes the case of a 70-year-old woman with an adnexal cystadenocarcinoma located in the right broad ligament and displaying a striking resemblance to a well-differentiated endometrioid adenocarcinoma. The uniqueness of this pseudoendometrioid carcinoma lies in the fact that its mesonephric nature is revealed by the origin from a papillary cystadenoma of the broad ligament, where remnants of the mesonephric duct are seated, and the immunohistochemical profile, particularly a uniform negativity for estrogen and progesterone receptors, apical-luminal positivity for CD10, and strong nuclear positivity for GATA3.
- 1 October 2015
- Published by Elsevier in Gynecologic Oncology
- Vol. 139 (1) , 118-126
Characterization of patient-derived tumor xenograft models of endometrial cancer for preclinical evaluation of targeted therapies
- 1 October 2015
- Published by Elsevier in Gynecologic Oncology
- Vol. 139 (1) , 118-126
Characterization of patient-derived tumor xenograft models of endometrial cancer for preclinical evaluation of targeted therapies
- 28 March 2015
- Published by Springer Nature in Pediatric Nephrology
- Vol. 30 (9) , 1443-1449
Termination of pregnancy for renal malformations
We studied the correlation between prenatal diagnosis and postmortem investigations in pregnancies terminated for renal malformations. Over a 5-year period, 77 cases of termination of pregnancy (TOP) for renal malformations were reviewed. Chromosomal anomalies (n = 9) and cases without conventional or virtual autopsy were excluded (n = 15). In 53 cases, prenatal ultrasound diagnosis and conventional autopsy findings were compared. In addition, we compared the accuracy of conventional and virtual autopsy findings in 17 cases. Full agreement was observed in 60.4 % (32/53) of cases. In 26.4 % (14/53) of the cases, the presence of additional malformations did not alter the final diagnosis. However, in 11.3 % (6/53) the final diagnosis was adjusted because of major additional findings. One case showed a total disagreement. Conventional and virtual autopsy were in full agreement in 52.9 % (9/17). Postmortem magnetic resonance imaging (MRI) description and detection of malformations was less complete and failed to correctly diagnose 5/17 cases (29.4 %). In 17.6 % (3/17) of the cases, postmortem MRI revealed malformations not confirmed by conventional autopsy. A high correlation between prenatal ultrasound and postmortem investigations was observed. Conventional autopsy remains the gold standard to reveal additional major and minor malformations, leading to a correct final diagnosis. The added value of virtual necropsy for renal pathology was limited.
- 28 March 2015
- Published by Springer Nature in Pediatric Nephrology
- Vol. 30 (9) , 1443-1449
Termination of pregnancy for renal malformations
We studied the correlation between prenatal diagnosis and postmortem investigations in pregnancies terminated for renal malformations. Over a 5-year period, 77 cases of termination of pregnancy (TOP) for renal malformations were reviewed. Chromosomal anomalies (n = 9) and cases without conventional or virtual autopsy were excluded (n = 15). In 53 cases, prenatal ultrasound diagnosis and conventional autopsy findings were compared. In addition, we compared the accuracy of conventional and virtual autopsy findings in 17 cases. Full agreement was observed in 60.4 % (32/53) of cases. In 26.4 % (14/53) of the cases, the presence of additional malformations did not alter the final diagnosis. However, in 11.3 % (6/53) the final diagnosis was adjusted because of major additional findings. One case showed a total disagreement. Conventional and virtual autopsy were in full agreement in 52.9 % (9/17). Postmortem magnetic resonance imaging (MRI) description and detection of malformations was less complete and failed to correctly diagnose 5/17 cases (29.4 %). In 17.6 % (3/17) of the cases, postmortem MRI revealed malformations not confirmed by conventional autopsy. A high correlation between prenatal ultrasound and postmortem investigations was observed. Conventional autopsy remains the gold standard to reveal additional major and minor malformations, leading to a correct final diagnosis. The added value of virtual necropsy for renal pathology was limited.
- Open Access
- 1 August 2014
- Published by Elsevier in The Breast
- Vol. 23 (4) , 371-377
Prognostic implications of lobular breast cancer histology: New insights from a single hospital cross-sectional study and SEER data
- 1 August 2014
- Published by Elsevier in The Breast
- Vol. 23 (4) , 371-377
Open AccessPrognostic implications of lobular breast cancer histology: New insights from a single hospital cross-sectional study and SEER data
- Open Access
- 29 May 2014
- Published by Springer Nature in BMC Medical Imaging
- Vol. 14 (1) , 19
The more you look, the more you find: challenging results on FDG-PET CT in a patient with neurofibromatosis type I
FDG-PET/CT is part of the standard diagnostic management of a patients with a large variety of common and less common malignant tumors, based on the increased glucose metabolism within tumors.
- 29 May 2014
- Published by Springer Nature in BMC Medical Imaging
- Vol. 14 (1) , 19
Open AccessThe more you look, the more you find: challenging results on FDG-PET CT in a patient with neurofibromatosis type I
FDG-PET/CT is part of the standard diagnostic management of a patients with a large variety of common and less common malignant tumors, based on the increased glucose metabolism within tumors.
- 1 September 2013
- Vol. 33 (9) , 3855-9
Immunological response after WT1 mRNA-loaded dendritic cell immunotherapy in ovarian carcinoma and carcinosarcoma.
Dendritic cell (DC)-based immunotherapy is an emerging new treatment option in ovarian cancer, an important cause of cancer-related mortality. One patient with ovarian carcinosarcoma (OCS) and one with serous ovarian cancer (SOC) received four weekly vaccinations of autologous DCs electroporated with mRNA coding for the Wilms' tumor gene 1 (WT1). Safety, feasibility and immunogenicity were assessed. Vaccination was feasible without toxicity. In an ex vivo antigen re-stimulation assay of peripheral blood mononuclear cells, both patients showed increasing cluster of differentiation 137 (CD137+) antigen-specific T-cells and interleukin 10 (IL-10) production post-vaccination. Moreover, interleukin-2 (IL-2) production increased (OCS) as well as interferon-gamma (IFN-γ) and tumor necrosis factor-alpha (TNF-α) (SOC). Disease in patients progressed after four vaccines and patients continued with conventional therapies. After cessation of immunotherapy, they had an extended survival of 19 (OCS) and 12 (SOC) months. To our knowledge, we report for the first time the feasibility and T-cell immunogenicity of WT1 mRNA-loaded DC immunotherapy in ovarian cancer.
- 1 September 2013
- Vol. 33 (9) , 3855-9
Immunological response after WT1 mRNA-loaded dendritic cell immunotherapy in ovarian carcinoma and carcinosarcoma.
Dendritic cell (DC)-based immunotherapy is an emerging new treatment option in ovarian cancer, an important cause of cancer-related mortality. One patient with ovarian carcinosarcoma (OCS) and one with serous ovarian cancer (SOC) received four weekly vaccinations of autologous DCs electroporated with mRNA coding for the Wilms' tumor gene 1 (WT1). Safety, feasibility and immunogenicity were assessed. Vaccination was feasible without toxicity. In an ex vivo antigen re-stimulation assay of peripheral blood mononuclear cells, both patients showed increasing cluster of differentiation 137 (CD137+) antigen-specific T-cells and interleukin 10 (IL-10) production post-vaccination. Moreover, interleukin-2 (IL-2) production increased (OCS) as well as interferon-gamma (IFN-γ) and tumor necrosis factor-alpha (TNF-α) (SOC). Disease in patients progressed after four vaccines and patients continued with conventional therapies. After cessation of immunotherapy, they had an extended survival of 19 (OCS) and 12 (SOC) months. To our knowledge, we report for the first time the feasibility and T-cell immunogenicity of WT1 mRNA-loaded DC immunotherapy in ovarian cancer.
- 24 January 2013
- Published by Wiley in Prenatal Diagnosis
- Vol. 33 (3) , 292-295
Prenatal diagnosis of MPPH syndrome
We report the prenatal sonographic detection of a fetus with megalencephaly, polymicrogyria, postaxial polydactyly and hydrocephaly. Only 14 patients have been reported in the literature so far, all but one were diagnosed postnatally. The polymicrogyria in the frontoparietal lobe was confirmed by prenatal magnetic resonance imaging. Additionally, a hypoplastic thymus as seen in a 22q11 deletion was present. Although polymicrogyria along with pre‐axial polydactyly has been described in 22q11 deletion, the diagnosis of Di George syndrome was ruled out. The etiology of megalencephaly, polymicrogyria, postaxial polydactyly and hydrocephaly has not been revealed yet. A dominant as well as recessive inheritance has been suggested. © 2013 John Wiley & Sons, Ltd.
- 24 January 2013
- Published by Wiley in Prenatal Diagnosis
- Vol. 33 (3) , 292-295
Prenatal diagnosis of MPPH syndrome
We report the prenatal sonographic detection of a fetus with megalencephaly, polymicrogyria, postaxial polydactyly and hydrocephaly. Only 14 patients have been reported in the literature so far, all but one were diagnosed postnatally. The polymicrogyria in the frontoparietal lobe was confirmed by prenatal magnetic resonance imaging. Additionally, a hypoplastic thymus as seen in a 22q11 deletion was present. Although polymicrogyria along with pre‐axial polydactyly has been described in 22q11 deletion, the diagnosis of Di George syndrome was ruled out. The etiology of megalencephaly, polymicrogyria, postaxial polydactyly and hydrocephaly has not been revealed yet. A dominant as well as recessive inheritance has been suggested. © 2013 John Wiley & Sons, Ltd.